Gamifant (emapalumab?lzsg) 10?mg – For Research Use Only

Gamifant (emapalumab?lzsg) 10?mg – For Research Use Only

$2.00

Gamifant (emapalumab?lzsg) is a human IgG1 monoclonal antibody that neutralizes interferon?gamma (IFN?). Supplied as 10?mg in 2?ml sterile injection vial. Produced by Patheon Italia under Chinese approval SJ20220008. Used in research on cytokine storm, macrophage activation, hemophagocytic lymphohistiocytosis (HLH) modeling. For laboratory research use only.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare

Description

Emapalumab?lzsg (branded as Gamifant) is the first IFN??neutralizing antibody approved for treating primary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS). In research, it serves as a potent tool to investigate hyperinflammatory disorders, IFN?-driven cytokine storm, macrophage activation, and immune dysregulation. It enables study designs involving immune suppression, CAR?T?related neurotoxicity models, and cytokine modulation experiments. For laboratory research use only.


Product Specifications

ParameterDetail
Product NameGamifant (emapalumab?lzsg) Injection
SynonymsEmapalumab; IFN??neutralizing antibody
Strength10?mg per vial (2?ml, 5?mg/ml)
Dosage FormIntravenous injection vial
Packaging1 vial per box
ManufacturerPatheon Italia S.p.A. (Italy)
Approval Number SJ20220008
Drug Standard Code86984083000013
BarcodeNot yet assigned
CAS NumberNot assigned (monoclonal antibody complex)
Molecular TypeHuman IgG1 monoclonal antibody (~148?kDa)

Mechanism of Action & Research Applications

Emapalumab?lzsg binds to and neutralizes interferon?gamma, inhibiting downstream signaling pathways that drive hyperinflammation. It is particularly suited for research into cytokine-driven immune activation, HLH and MAS models, CAR?T cell therapy–related toxicity, and the pharmacodynamics of immune suppression via IFN? blockade.


Side Effects (For Reference Only in Research Models)

Analogous clinical observations include infection risk (especially viral), infusion-related reactions, hypertension, fever, and hematologic changes. These inform model safety and dosing protocols in experimental designs.


Disclaimer

Gamifant (emapalumab?lzsg) is strictly intended for laboratory research use only. Not for therapeutic, diagnostic, or prophylactic use in humans or animals.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Gamifant (emapalumab?lzsg) 10?mg – For Research Use Only”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare